glp-1 strength training program Program: Enhance & Combat Muscle Loss iFIT | 6 Week Plan
Description
There is emerging evidence for GLP-1 receptor agonists as renoprotective agents, but their role in slowing progression to end-stage kidney disease is yet to be established

Get Started

PMID: 39937469

A very recent study by Principe D

So what about that CONQUER trial
